XML 64 R49.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Total stock‑based compensation expense consists of the following:
Year Ended December 31,
202420232022
Restricted stock and RSUs expense
$58,921 $54,606 $40,754 
Bonus Plan expense (see Note 11)12,344 14,801 28,571 
ESPP expense (see Note 13)2,426 2,407 2,890 
Stock grants expense600 600 450 
Stock option expense— 343 2,150 
DCP elective participant deferrals expense (1) (see Note 12)
126 215 391 
Total stock-based compensation expense (2)
$74,417 $72,972 $75,206 
(1)DCP elective participant deferrals expense excludes deferred incentive bonus payable pursuant to the Bonus Plan.
(2)As of December 31, 2024 and 2023, $1,556 and $4,043 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively.
Total stock‑based compensation expense is included in the consolidated statements of operations as follows:
Year Ended December 31,
202420232022
Cost of subscriptions and licenses$1,506 $4,444 $2,781 
Cost of services3,142 3,196 2,055 
Research and development20,862 19,380 27,209 
Selling and marketing12,972 11,565 8,898 
General and administrative35,935 34,387 34,263 
Total stock-based compensation expense$74,417 $72,972 $75,206 
Schedule of Restricted Stock and Restricted Stock Unit Activity
The following is a summary of unvested restricted stock and RSUs activity and related information:
Time-Performance-
BasedBased
Time-WeightedWeighted
TotalBasedAverageAverage
RestrictedRestrictedPerformance-Grant DateGrant Date
StockStockBasedFair ValueFair Value
and RSUsand RSUsRSUsPer SharePer Share
Unvested, December 31, 20233,303,849 2,938,208 
(3)
365,641 
(5)
$39.87 $39.21 
Granted1,661,929 
(1)
1,455,017 
(4)
206,912 
(6)
50.4849.49
Vested(1,237,464)(1,055,674)(181,790)38.06 39.15 
Forfeited and canceled(311,305)(269,848)(41,457)40.68 43.42 
Unvested, December 31, 20243,417,009 
(2)
3,067,703 349,306 $45.45 $44.83 
(1)For the year ended December 31, 2024, the Company only granted RSUs.
(2)Includes 34,652 RSUs which are expected to be settled in cash.
(3)Includes 199,076 time‑based RSUs granted during the three months ended March 31, 2022 to certain officers and key employees, which cliff vest on January 31, 2025.
(4)Includes 300,964 time‑based RSUs granted during the three months ended June 30, 2024 to certain officers, which vest 20% on each of December 15, 2025, 2026, 2027, 2028, and 2029.
(5)Primarily relates to the 2023 annual performance period. Includes 185,186 performance‑based RSUs granted during the year ended December 31, 2022 with extraordinary terms, which are described below.
(6)Primarily relates to the 2024 annual performance period. Includes 1,335 additional shares earned based on the achievement of 2023 performance goals for performance-based RSUs granted during the year ended December 31, 2023.
Schedule of Stock Option Activity
The following is a summary of stock option activity and related information:
Weighted
Average
StockExercise Price
OptionsPer Share
Outstanding, December 31, 2023916,429 $5.74 
Exercised(911,429)5.74 
Forfeited and expired(5,000)5.74 
Outstanding, December 31, 2024— $0.00